EMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Eastman Chemical Co (EMN) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has positive analyst sentiment, hedge fund buying activity, and potential benefits from rising commodity prices. While financial performance has been weak recently, the long-term outlook and improving margins make it a suitable investment opportunity.
The technical indicators suggest a neutral to slightly bullish trend. The MACD is above 0 and positively contracting, moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the RSI is neutral at 49.379. The stock is trading close to its pivot level of 73.806, with support at 71.566 and resistance at 76.047.
JPMorgan upgraded the stock to Overweight with a price target of $80, citing benefits from rising commodity prices.
Hedge funds have significantly increased their buying activity, up 626.44% over the last quarter.
Analysts project gains from higher ethylene and propylene prices, with an estimated $282 million benefit by 2026.
Weak financial performance in Q4 2025, with revenue down -12.12% YoY and net income down -68.18% YoY.
Gross margin dropped significantly by -30.59% YoY, reflecting operational challenges.
In Q4 2025, Eastman Chemical reported a revenue decline of -12.12% YoY to $1.97 billion, net income dropped -68.18% YoY to $105 million, and EPS fell -67.49% YoY to $0.92. Gross margin decreased to 17.13%, down -30.59% YoY, indicating significant financial headwinds.
Analysts are generally bullish on Eastman Chemical. Recent upgrades include JPMorgan raising its price target to $80 and UBS increasing its target to $88. Citi, Jefferies, and others maintain Buy ratings with targets ranging from $83 to $89, reflecting optimism about improving margins and benefits from rising commodity prices.
